Smithkline Beckman Corp said genetically engineered hepatitis B vaccine received regulatory approval marketing Switzerland Luxembourg .
The vaccine , called Engerix-B , approved several country , including Belgium Hong Kong .
Smithkline said currently considering marketing avenue United States .
Merck Co & lt ; MRK > also genetically engineered vaccine marketed several foreign market , according industry source .
Reuter & # 3 ; 